Z-1672-2020 Class II Terminated
FDA device recall Z-1672-2020 was initiated by Qualigen Inc on Nov 6, 2019 and is designated Class II. Reason for recall: The chemiluminescent immunoassay has been noted to have higher than expected results which may result in inaccurate quantitative determinations of Sex Hormone Binding Globulin in human serum and… The recall status is terminated (terminated Sep 23, 2020). Affected quantity: 24 Kits (30 test packs each) 720 tests.
Recall details
- Product Type
- Devices
- Report Date
- Apr 15, 2020
- Initiation Date
- Nov 6, 2019
- Termination Date
- Sep 23, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 24 Kits (30 test packs each) 720 tests
Product description
Reason for recall
Distribution pattern
US Nationwide distribution in the states of AL, AK, CA, HI, and TX.
Code information
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1672-2020
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Qualigen Inc? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.